SCHEMBL29270785

SCHEMBL29270785

Cc1ccc2c(c1)SC[C@H](NC(=O)OC(C)(C)C)C(=O)N2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.43
▸ EPHX2 P34913 2/20 0.42
▸ KDM4E B2RXH2 5/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ MAPT P10636 3/20 0.41
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ NFKB1 P19838 2/20 0.37
▸ NFKB2 Q00653 2/20 0.37
▸ RELA Q04206 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ ALOX12 P18054 1/20 0.36
▸ NAAA Q02083 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30675690 0.88 GAA (0.43) GAAEPHX2SMN1; SMN2NFKB1NFKB2
SCHEMBL25766504 0.88 GAA (0.43) GAAEPHX2SMN1; SMN2NFKB1NFKB2
SCHEMBL29270789 0.88 GAA (0.43) GAAEPHX2KDM4ESMN1; SMN2NFKB1
SCHEMBL29270803 0.88 GAA (0.43) GAAEPHX2KDM4ESMN1; SMN2NPSR1
SCHEMBL3484898 0.86 EPHX2 (0.49) GAAEPHX2KDM4EHSD17B10HTT
SCHEMBL3484895 0.86 EPHX2 (0.49) GAAEPHX2KDM4EHSD17B10HTT
SCHEMBL26962099 0.83 GAA (0.44) GAAEPHX2KDM4ESMN1; SMN2LMNA
SCHEMBL5735937 0.82 GAA (0.42) GAAEPHX2SMN1; SMN2MEN1KMT2A
SCHEMBL5969627 0.82 GAA (0.42) GAAEPHX2SMN1; SMN2MEN1KMT2A
SCHEMBL25584629 0.82 GAA (0.42) GAAEPHX2SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116964048-A Bicyclic tetrahydroazepine derivatives for the treatment of cancer 豪夫迈·罗氏有限公司 2023-10-27 — — CN disclosed
Send feedback